Skip to content Skip to footer

International Cannabis Weekly: 271

October 28, 2022

Highlights

Share this story

90% OF TICKETS NOW SOLD FOR BUSINESS OF CANNABIS: NEW YORK

There’s just one week to go until business leaders descend upon the New York Academy of Medicine for a special day-long program of New York state policy makers, prominent investors and industry executives. 90% of tickets have now been sold – secure your seat today.

The New York cannabis market is about to explode and momentum is building as businesses try to navigate this newly legal state. Business of Cannabis: New York will explore everything from regulation to investment, licensing to social equity – and everything in between.

Connect and collaborate with industry leaders on 3 November. Get your tickets today before they sell out imminently.

BUY NOW »

GERMANY SET TO BECOME EUROPE’S LARGEST LEGAL CANNABIS MARKET

READ MORE »

BIDEN SAYS CANNABIS PARDONS WILL NOT EXTEND TO THOSE WHO SOLD CANNABIS

READ MORE »

Highlights

Share this story
Europe
  • The European Commission still has to give the green light for new German legislation.
  • Inflammatory bowel disease patients report improvements with medical cannabis in a new study.
  • Hemp could be the solution to delivering growth in agriculture and boost the UK economy.
  • The regional council in Calabria has unanimously approved the regional law on dispensing medical cannabis.
  • Medicinal cannabis dispensing on the Isle of Man has been further delayed over technical issues.
  • Dutch growers who have been selected to take part in the governments cultivation trials have been delayed.
  • High-THC cannabis flower has been linked to improvements in quality of life and reducing anxiety.
  • French MP has tabled an amendment to the social security bill to relaunch the debate on cannabis legalisation.
  • Growing hemp has proved successful in removing harmful chemicals from topsoil and purifying polluted water.
  • SynBiotic has seen a 15% increase in its stock price this week, helping rescue its share price from historic lows.

 

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Upcoming event

CANNABIS EUROPA LONDON RETURNS ON 2-3 MAY 2023

Cannabis Europa 2023 will be returning to The Barbican Centre for our industry leading conference. We will once again be holding a boutique industry expo, showcasing more than 50 leading businesses as the cream of the European cannabis crop, acting as a jumping-off point for growing your business in Europe and beyond.

Join 1,500 leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians – a crucial combination to drive your business forward and to navigate this ever-changing field.

Book your place for 2-3 May 2023 now – join the global industry in London to set the framework for cannabis going mainstream across Europe.

BUY YOUR TICKET »

Highlights

Share this story
Canada

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC
  • ECS Botanics Holdings Ltd has announced it has offloaded its Tasmanian business and assets.
  • Cann Group is aiming to raise another A$10 million via a share purchase plan to expand its manufacturing capabilities.
  • Wellnex Life has raised A$5 million in investment as it looks to dominate the Australian medical cannabis market.
  • Kyung Hee University Medical Centre is set to conduct a study on the effectiveness of medical cannabis.
  • Hong Kong is set to ban CBD, with up to 7 years in jail for possession to match heroin and cocaine.
  • Over 1,000 clinics offering cannabis-based treatments have opened since the start of the year in Thailand.

Highlights

Share this story
New Report

If you haven’t already, then download the Asian Cannabis Report: 2nd Edition to get insight into the evolution – and future trajectory – of the cannabis industry in Asia.

To complement the report, we have two premium packages available. The first is Prohibition Partners’ proprietary market sizing data, which includes country-by-country forecasts of the medical, CBD and adult-use cannabis markets in Asia. Market sizing forecasts are provided for countries in Asia, including: Japan, Taiwan, South Korea, Thailand, India, Malaysia, Nepal and Sri Lanka.

The second package is a 20-page guide entitled Business Insights into the Thai Cannabis Market. Both can be purchased for £990, saving you £90.

SEE PREMIUM PACKAGES »

Highlights

Share this story
Africa & The Middle East
  • An Israeli company has cloned hemp cells and used a bioreactor to grow cannabis with 12 times the potency.
  • ZIDA has called upon investors to inject funds into the Zimbabwe medicinal cannabis sector for growth.
  • MediCane has announced the first patient has been enrolled in its clinical trial to reduce the symptoms of dementia.
Latest Issues

275

274

273

272

271

270

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.